Selected Grants
Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029NEUROD1 function in SCLC fate and plasticity
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Coordinating Center for the NCI Small Cell Lung Cancer Research Consortium
ResearchPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2022 - 2027Training Program in Developmental and Stem Cell Biology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027Duke Research Training Program in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029NEUROD1 function in SCLC fate and plasticity
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Coordinating Center for the NCI Small Cell Lung Cancer Research Consortium
ResearchPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2022 - 2027Training Program in Developmental and Stem Cell Biology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027Otolaryngology Surgeon- Scientist career Path (OSSP) program
Inst. Training Prgm or CMEMentor · Awarded by National Institute on Deafness and Other Communication Disorders · 2022 - 2027Mechanisms of Arginine Deprivation in Small Cell Lung Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2026Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Uncovering novel vulnerabilities to treat SCLC therapy resistance
ResearchCollaborator · Awarded by Lung Cancer Research Foundation · 2023 - 2025Investigating and targeting metabolic vulnerabilities of MYC-driven small cell lung cancer
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025Pharmacological Sciences Training Grant
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2020 - 2025Pro-tumor functions of neutrophils in squamous cell lung cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2025Aur1959 inhibition in small cell lung cancer (SCLC)
ResearchPrincipal Investigator · Awarded by Auron Therapeutics · 2023 - 2024SOX9 promotes a unique immunogenic state in small cell lung cancer (SCLC)
FellowshipPrincipal Investigator · Awarded by Lung Cancer Initiative of North Carolina · 2023 - 2024Targeting SCLC plasticity with constellation pharmacology
ResearchPrincipal Investigator · Awarded by University of Utah · 2022 - 2023Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung Cancer
ResearchPrincipal Investigator · Awarded by Washington University in St. Louis · 2022 - 2022Fellowships, Gifts, and Supported Research
Investigating and targeting metabolic vulnerabilities of MYC-driven small cell lung cancer ·
September 2022
- August 2025
Mentor ·
National Institutes of Health
Ireland, Abbie F31
External Relationships
- American Association for Cancer Research
- Auron Therapeutics
- Feinberg School of Medicine Northwestern University
- Fox Chase Cancer Center
- Genes & Development
- American Association for Cancer Research
- Auron Therapeutics
- Feinberg School of Medicine Northwestern University
- Fox Chase Cancer Center
- Genes & Development
- Lung Cancer Research Foundation
- Memorial Sloan Kettering Cancer Center
- Moffit Cancer Center
- Nuage Therapeutics
- Purdue University
- US Patent
- University of California Los Angeles
- University of Pennsylvania
- Vanderbilt University
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.